| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | PRIME DIVIDEND CORP. Monthly Dividend Declaration for Class A & Preferred Share | ||
| Mo | US FINANCIAL 15 SPLIT CORP. Preferred Dividend Declared | ||
| Mo | FINANCIAL 15 SPLIT CORP. Monthly Dividend Declaration for Class A & Preferred Share | ||
| Mo | M SPLIT CORP. Monthly Dividend Declared for Class I and Class II Preferred Shares | ||
| Mo | New Commerce Split: Commerce Split Monthly Payments Declared for Capital Share and Preferred Shares | ||
| Mo | Netcompany Group A/S: Transactions in connection with share buyback programme | ||
| Mo | Novo Nordisk A/S - share repurchase programme | ||
| Mo | 1847 Holdings LLC: 1847 Holdings Subsidiary Wolo Receives Approval of Amazon Brand Registry, Expanding E-Commerce Presence | ||
| Mo | AVAX One Technology Ltd.: AVAX One Announces Development of Initial 10 MW Tier 3 AI/HPC Powered Land in Alberta | ||
| Mo | Allogene Therapeutics, Inc.: Allogene Therapeutics Showcases Momentum with Clinical and Platform Advancements in Allogeneic CAR T at AACR 2026 | ||
| Mo | ENvue Medical, Inc.: ENvue Medical Announces 40th U.S. Hospital Customer with Addition of a Virginia Medical Center Affiliated with the Mayo Clinic Care Network | ||
| Mo | CytoDyn Inc.: CytoDyn Presents New Leronlimab Data in Metastatic Triple-Negative Breast Cancer at AACR Annual Meeting 2026 | ||
| Mo | SAIC, Inc.: SAIC Awarded New $75.2M PRISM Task Order to Advance the Naval Air Systems Command's Mission-Critical Aviation Systems | ||
| Mo | A.P. Møller - Mærsk A/S: Transactions in connection with share buy-back program | ||
| Mo | Nayax Ltd.: Nayax at the NAMA Show 2026: Turning Payment Complexity into a Competitive Edge | ||
| Mo | PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order | ||
| Mo | Helus Pharma Expresses Support for Executive Order Advancing Psychedelic Research and Regulatory Pathways for Serious Mental Health Conditions | ||
| Mo | Fiserv, Inc.: Fiserv to Release First Quarter Earnings Results on May 5, 2026 and Confirms Details for May 14, 2026 Investor Day | ||
| Mo | ASML reports transactions under its current share buyback program | ||
| Mo | BioCardia, Inc.: BioCardia and Japan PMDA Align on Acceptability of CardiAMP Clinical Data to Support Regulatory Approval in Ischemic Heart Failure | ||
| Mo | Kyverna Therapeutics, Inc.: Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks | ||
| Mo | Enlight Renewable Energy Ltd.: Enlight to Report First Quarter 2026 Financial Results on Tuesday, May 5, 2026 | ||
| Mo | LENZ Therapeutics, Inc.: LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ for the Treatment of Presbyopia in the United Kingdom | ||
| Mo | Calidi Biotherapeutics, Inc: Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026 | ||
| Mo | Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026 |